These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2969799)

  • 21. Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.
    Distler A; Haerlin R; Hilgenstock G; Passfall J
    Drugs; 1990; 40 Suppl 4():21-7; discussion 28-30. PubMed ID: 2092965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and safety of pindolol and alpha-methyldopa in treatment of mild to moderate hypertension: results of a double-blind evaluative study.
    Beanlands DS; Allard PP; Wilson M; Orbeck KW; Helman AB; Lefebvre R
    Clin Invest Med; 1978; 1(3-4):139-45. PubMed ID: 391453
    [No Abstract]   [Full Text] [Related]  

  • 24. Disparate effects of methyldopa and clonidine on cardiac mass and haemodynamics in rats.
    Ishise S; Pegram BL; Frohlich ED
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():449s-452s. PubMed ID: 6450019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol.
    Fernandez PG; Kim BK; Reichek N; Ko P; Gill V; McDonald J; Furlong L; Lewis H; Nolan R; McManamon P
    Curr Med Res Opin; 1984; 8(10):720-33. PubMed ID: 6233093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide.
    Moyer RR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1250-3. PubMed ID: 6356853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S; Andrivet P; Piquet J; Brun-Buisson C; Rauss A; Bignon J; Lemaire F
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical evaluation of prazosin, a new antihypertensive agent.
    Pitts NE
    Postgrad Med; 1975 Nov; Spec No():117-27. PubMed ID: 1105484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of mild hypertension with urapidil or captopril.
    Rosenthal J; Schäfer N; Haerlin R; Wurst W; Solleder P
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):233S-236S. PubMed ID: 3046630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
    Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
    Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular adjustment to antiadrenergic agents.
    Pegram BL; Frohlich ED
    Am J Med; 1983 Sep; 75(3A):94-9. PubMed ID: 6137951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C; Barros LM; Batlouni M; Sousa JE
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
    Arosio E; Pancera P; Sheiban I; Priante F; Ribul M; De Marchi S; Tonni S; Lechi A
    J Hum Hypertens; 1996 Mar; 10(3):171-6. PubMed ID: 8733035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of oxprenolol vs methyldopa as second-line antihypertensive agents in the elderly.
    Traub YM
    Arch Intern Med; 1988 Jan; 148(1):77-80. PubMed ID: 3276279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
    Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B
    Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echocardiographic studies of regression of left ventricular hypertrophy in hypertension.
    Fouad-Tarazi FM; Liebson PR
    Hypertension; 1987 Feb; 9(2 Pt 2):II65-8. PubMed ID: 2948912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac morphology and function in arterial hypertension. The effects of a new multifactorial hypotensive agent: urapidil.
    Ghione S; Genovesi-Ebert A; Marabotti C; Spinazzi A; Noseda A
    Blood Press Suppl; 1994; 4():25-30. PubMed ID: 7804509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.